riboclib
Novartis breast cancer drug secures FDA fast-track status
November 1, 2016Manufacturing and Production, Sales and Marketing Novartis, Pfizer, ibrance, letrozole, riboclib
Novartis has announced that its product ribociclib (LEE011) has been granted fast-track review status as a first-line treatment of advanced …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
